Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-05

Clinical Trial Update: Lithium Versus Quetiapine in Treatment Resistant Depression [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lithium to quetiapine for treatment-resistant depression; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lithium (Lithium carbonate)
  • Quetiapine (quetiapine)

Snippet

Sponsor: King's College London | Conditions: Depressive Disorder, Treatment-Resistant | Phase 4 | Status: UNKNOWN